ANCHOR Diagnostics has entered into a strategic distribution partnership with XboXLab, strengthening support for molecular diagnostics in the Nordic region, specifically including Sweden, Norway, and Finland.
Since its founding in Sweden in 2016, XboXLab has established itself as a technically focused distributor with strong laboratory connections throughout the Nordic region. establishing operations in Norway in 2019 and Finland in 2020. The company expanded into Norway in 2019 and Finland in 2020, building expertise in supporting laboratories with molecular diagnostic technologies that balance performance with practical usability.
Nordic laboratories will now have direct access to ANCHOR Diagnostics’ rapid PCR portfolio, enabling faster diagnostic turnaround times while maintaining the accuracy and consistency required for clinical decision-making and research applications.
This partnership reflects a shared philosophy: molecular diagnostics should be fast, reliable, and straightforward to implement. Both companies emphasize solutions that work effectively in real laboratory environments, where operational efficiency, technical support, and consistent performance matter most.
The collaboration delivers:
- Comprehensive Nordic coverage across three countries
- Local technical expertise through established laboratory relationships
- 30-minute molecular testing solutions designed for routine workflows
- Responsive support aligned with regional market needs
By working with XboXLab, ANCHOR Diagnostics ensures its diagnostic technologies are supported by a partner with deep Nordic market knowledge and a proven track record in laboratory engagement.
This marks another milestone in ANCHOR Diagnostics’ European expansion strategy, connecting advanced molecular diagnostics with the local expertise laboratories need.
To learn more about XboXLab, click here.
